reported that higher sPD-L1 levels were related to poor OS and disease-free survival/recurrence-free survival/tumor-free survival/time to progression in hepatocellular carcinoma in a meta-analysis of 1291 patients [39]. This evidence concerns the gene SPDL1 and hepatocellular carcinoma.